Technical Analysis for TRVN - Trevena, Inc.

Grade Last Price % Change Price Change
grade B 1.7 1.19% 0.02
TRVN closed up 1.19 percent on Friday, March 22, 2019, on 20 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical TRVN trend table...

Date Alert Name Type % Chg
Mar 22 Narrow Range Bar Range Contraction 0.00%
Mar 22 NR7 Range Contraction 0.00%
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Inside Day Range Contraction 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 21 Slingshot Bullish Bullish Swing Setup 1.19%
Mar 21 Upper Bollinger Band Walk Strength 1.19%
Mar 21 Wide Bands Range Expansion 1.19%
Mar 21 Overbought Stochastic Strength 1.19%
Mar 21 Upper Bollinger Band Touch Strength 1.19%

Older signals for TRVN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Trevena, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing therapeutics for G protein coupled receptors. Its products include TRV027 that has completed Phase 2a clinical trials for the treatment of acute heart failure; TRV130, a small molecule G protein biased ligand at the µ-opioid receptor has completed Phase 1b clinical trials to treat moderate to severe acute pain intravenously; TRV734 that is in preclinical studies as a orally administered treatment of moderate to severe acute and chronic pain; and d-opioid receptor G protein biased ligand therapeutics for the treatment of central nervous system disorders. The company was formerly known as Parallax Therapeutics, Inc. and changed its name to Trevena, Inc. in January 2008. Trevena, Inc. was founded in 2007 and is based in King of Prussia, Pennsylvania.
Pain Organic Compounds Central Nervous System Disorders Analgesics Cell Signaling Pyridines Signal Transduction Opioid Treatment Of Central Nervous System Disorders Acute Heart Failure Thiophenes Trevena Inc
Is TRVN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.58
52 Week Low 0.38
Average Volume 4,356,209
200-Day Moving Average 1.2759
50-Day Moving Average 1.2448
20-Day Moving Average 1.525
10-Day Moving Average 1.614
Average True Range 0.1335
ADX 34.66
+DI 37.2217
-DI 18.6804
Chandelier Exit (Long, 3 ATRs ) 1.5995
Chandelier Exit (Short, 3 ATRs ) 1.6705
Upper Bollinger Band 1.8241
Lower Bollinger Band 1.2259
Percent B (%b) 0.79
BandWidth 39.22623
MACD Line 0.127
MACD Signal Line 0.1164
MACD Histogram 0.0106
Fundamentals Value
Market Cap 101.48 Million
Num Shares 59.7 Million
EPS -1.94
Price-to-Earnings (P/E) Ratio -0.88
Price-to-Sales 0.00
Price-to-Book 1.66
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.79
Resistance 3 (R3) 1.79 1.76 1.78
Resistance 2 (R2) 1.76 1.74 1.76 1.77
Resistance 1 (R1) 1.73 1.72 1.75 1.73 1.76
Pivot Point 1.70 1.70 1.71 1.70 1.70
Support 1 (S1) 1.67 1.68 1.69 1.67 1.64
Support 2 (S2) 1.64 1.66 1.64 1.63
Support 3 (S3) 1.61 1.64 1.63
Support 4 (S4) 1.61